Mice with cardiac-specific overexpression of Cav-3 exhibited augmentation of natriuretic peptide expression and nuclear Akt phosphorylation, resulting in reduced cardiac hypertrophy following TAC, with improved cardiac function and increased survival suggesting a potential therapeutic role for Cav-3 in heart failure (Horikawa et al., 2011). This evidence concerns the gene CAV3 and heart failure.